Gambro is a Swedish-based medical technology company that develops, manufactures and supplies products and therapies for kidney and liver dialysis, myeloma kidney therapy and other extracorporeal therapies for chronic and acute patients.
The deal may be finalized within two weeks. Baxter has been negotiating with Gambro for almost a year.
Baxter International is headquartered in Deerfield, Ill.
Related Articles on Company Acquisitions:
Alcon Acquires Ophthalmic Division of Sensomotoric Instruments
Wright Medical to Acquire BioMimetic Therapeutics
Allergan to Acquire SkinMedica
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
